Transgenic mice with pigmented intraocular tumors: Tissue of origin and treatment

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 13, 1998, Pages 2800-2805

  Syed, Nasreen A ^a   Windle, Jolene J ^b   Darjatmoko, Soesiawati R ^c   Lokken, Janice M ^c   Steeves, Richard A ^c   Chappell, Rick ^d   Wallow, Ingolf H L ^c   Koop, Barbara A ^b   Mangold, Gina ^b   Howes, Kimberly A ^b   Albert, Daniel M ^c,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CTRC Institute for Drug Development   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE;

ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAOCULAR TUMOR; IRRADIATION; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PENETRANCE; PIGMENT EPITHELIUM; PIGMENTATION; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; DACARBAZINE; FAS LIGAND PROTEIN; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM PROTEINS; PIGMENT EPITHELIUM OF EYE; S100 PROTEINS; UVEAL NEOPLASMS;

EID: 0031793765     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bradl M, Klein-Szanto A, Porter S, Mintz B. Malignant melanoma in transgenic mice. Proc Natl Acad Sci USA. 1991;88:164-168.
2. Anand R, Ma D, Alizadeh H, et al. Characterization of intraocular tumors arising in transgenic mice. Invest Ophthalmol Vis Sci. 1994;35:3533-3539.
3. Kluppel M, Beermann F, Ruppert S, Schmid E, Hummler E, Schutz G. The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc Natl Acad Sci USA. 1991;88:3777-3781.
4. Hanahan D. Heritable formation of pancreatic B-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 1985;315:115-122.
5. Hogan B, Beddington R, Constantini F, Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory-Press; 1994.
6. Howes KA, Lasudry J, Albert D, Windle J. Photoreceptor cell tumors in transgenic mice. Invest Ophthalmol Vis Sci. 1994;35: 342-351.
7. Shternfeld I, Lasudry J, Chappell R, Darjatmoko J, Albert D. Anti-neoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma. Arch Ophthalmol. 1996;114:1396-1401.
8. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege (see comments). Science. 1995;270:1189-1192.
9. Imesch P, Bindley C, Khademian Z, et al. Melanocytes and iris color: electron microscopic findings. Arch Ophthalmol. 1996;114: 443-447.
10. Windle J, Albert D, O'Brien J, et al. Retinoblastoma in transgenic mice. Nature. 1990;343:665-669.